Hi-Q Marine Biotech - Oligo Fucoidan Expert

Hi-Q's research on Oligo Fucoidan goes far beyond oncology — covering 11 additional health areas:
Kidney disease · Fatty liver · Type 2 diabetes · Sarcopenia · Asthma · Eczema · Osteoarthritis · Cardiovascular disease · Gout · Gastric ulcers · Obesity

All backed by 60+ peer-reviewed publications and multiple human clinical trials.
One compound. Decades of research. Countless possibilities.

Based on scientific research. Not intended as medical advice. Consult your healthcare provider.

My morning routine ☀️

✔️ ONCOFUCO — on an empty stomach
✔️ Oatmeal + mixed nuts
✔️ Milk + fresh green salad

Eating well is the gentlest way to take care of yourself. 🤍

14 cancers. One natural compound. 🌿

Hi-Q's research on low-molecular-weight fucoidan covers 14 cancer types — from lung, liver, and colorectal, to leukemia, lymphoma, and brain cancer.
Research shows it may help induce apoptosis, suppress metastasis, regulate immunity, and ease chemo side effects.
📊 Disease control rates improved up to 24% when combined with standard therapies — and 95%+ in liver cancer cases.
Not a replacement for medicine. A powerful complement to it.

Based on scientific research. Not intended as medical advice. Consult your healthcare provider.

🌿🫀
Is alcohol slowly damaging your liver? Here's what science says can help. 👇

Alcohol doesn't just cause hangovers — it triggers a chain reaction inside your liver: free radical damage, chronic inflammation, fat accumulation, and over time, scarring (fibrosis). Left unchecked, this can progress into serious liver disease.

That's where Oligo-Fucoidan — a bioactive compound derived from brown seaweed — comes in. Research shows it offers multi-layered protection for your liver:

🛡️Neutralizes free radicals
Clears toxic byproducts generated during alcohol metabolism, protecting liver cells from oxidative damage.

🔬Activates your liver's repair system
It binds to ASGR receptors on liver cells and activates the STAT3 signaling pathway — a proven mechanism for preventing alcoholic hepatitis, acute liver injury, and fatty liver disease.

🧬Resets liver cell function at the genetic level
By inducing P1-HNF4A expression, it helps restore healthy transcription networks inside liver cells — essentially giving them a fresh start.

🚫Blocks fat buildup & fibrosis
It downregulates genes linked to fat synthesis and scarring, stopping the progression from fatty liver → fibrosis → liver cancer before it starts.

Nature gave us an incredible tool from the ocean. Science is now proving why it works. 🌊

💬 Have questions about liver health or Oligo-Fucoidan? Drop them in the comments below!

👉 Follow us for more science-backed wellness content.
🔗 Learn more from the papers:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4344618/
https://pubmed.ncbi.nlm.nih.gov/24731788/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6836049/

When it comes to treating unresectable liver cancer, we’re not just looking for results—we’re looking for a better quality of life.

Latest clinical data reveals that combining TACE with Oligo-Fucoidan is a total game-changer:

📈 95.2% Disease Control Rate: An incredible leap in treatment efficacy.

🛡️ Protecting Liver Function: Over 80% of patients maintained peak condition (Child-Pugh A).

In the fight against cancer, our mission is clear: Don’t just target the tumor—protect the patient. 🤝

Find out why this duo is becoming the golden partner in modern therapy. 🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC12442522/

That day, encountering ONCOFUCO changed the lives of some families.

Although the video shifted quickly, introducing the product to family members was not an easy task.

It presented our family’s story in another way.

For those walking this difficult path, maintaining strength and appetite can make all the difference.
ONCOFUCO helps support what matters most during treatment — boosting immune function and restoring appetite — so you or your loved one can hold on to energy, nourishment, and a better quality of life, one day at a time.

And you?
How did you begin this journey?
During this time, how did you face it? ❤️Share your story — comment below. 👇

April 17 is World Haemophilia Day.
It honors Frank Schnabel, a patient and advocate who founded the World Federation of Hemophilia.

Haemophilia is a rare inherited bleeding disorder.
If it runs in your family, it’s important to talk to a doctor about genetic counseling and testing.

For people living with haemophilia, regular factor treatment, joint protection, and avoiding high‑impact sports can help prevent bleeding.
Soft toothbrushes and the right pain relief—under a doctor’s guidance—also make a big difference.

If you notice pain, swelling, or unusual bruising, early treatment is key.
On the path to essential care, ONCOFUCO stands by you every day.

Awareness, education, and proper care can help people with haemophilia live safer, healthier lives.

New Hope for Lung Cancer Patients 🌊
Chemo. Radiation. Side effects that wear you down.
For NSCLC patients, the journey is tough — but science just got more promising.
A new clinical study shows that Oligo Fucoidan, a natural compound brown algae, can make a real difference as an add-on therapy:
📈 Survival rate jumped from 20% → 28.6% at two years
💪 Immune boost — more CD19 lymphocytes, lower inflammation
😮‍💨 Better daily life — less pain, breathlessness & insomnia
✅ Kidney & liver safe — no compromise on your body's core functions
No miracle claims. Just peer-reviewed research pointing toward a smarter way to fight back.

Drop a ❤️ if this was helpful, or share with someone who needs hope today.

Research👉https://pubmed.ncbi.nlm.nih.gov/38974912/

Fighting Triple-Negative Breast Cancer (TNBC)? Groundbreaking research reveals that Oligo-Fucoidan is a powerful scientific ally!

🎮 Cellular Remote Control: It precisely "turns on" anti-cancer defenses (upregulates miR-29c) while "switching off" growth signals (downregulates miR-17-5p) by regulating microRNA axes.
🍞 Starve the Tumor: It blocks glucose uptake, cutting off the energy cancer cells need to survive and spread.
🛡️ Immune Boost: It activates "killer" M1 macrophages to help prevent post-surgical recurrence and lung metastasis.

Studies show that supplementing standard therapy (like Olaparib) significantly improves outcomes and reduces the risk of relapse.
👉https://pubmed.ncbi.nlm.nih.gov/27994679/
👉https://pubmed.ncbi.nlm.nih.gov/36109724/